Previous Page  21 / 30 Next Page
Information
Show Menu
Previous Page 21 / 30 Next Page
Page Background

Page 51

Notes:

Journal of Ecosystem & Ecography | ISSN: 2157-7625 | Volume: 8

June 28-29, 2018 | Alexandria, Egypt

International Pre Conference Workshop on

Microbial Ecology & Eco Systems

Quantitative estimation of interleukin-17 in patients with chronic liver disorders

Noha A Ghazy, Hadeer S Okasha

and

Mona G Morsi

Faculty of Medicine Medical Microbiology & Faculty of Medicine Medical Microbiology & Immunology, Alexandria, Egypt

M

ore than 20 years after the discovery of the HCV, it is now well established that HCV is of global importance affecting all

countries, leading to a major global health problem that requires widespread active interventions for its prevention and

control. Chronic hepatitis C was linked to the development of cirrhosis and hepatocellular carcinoma (HCC) in many areas

of the world. WHO reported that Egypt has the highest prevalence (22%) in the world which explained by the past practice

of parenteral therapy for schistosomiasis. T cells that produce IL-17 have recently been identified as a third distinct subset of

effector T cells, and emerging data implicate Th17 cells as important in the pathogenesis of chronic hepatitis C infection by

regulating innate and adaptive immunity, including autoimmunity. So the present study was conducted to determine the role

of IL-17, with its potent pro-inflammatory properties, among chronic hepatitis C cases with or without cirrhosis and HCC

aimed at future immune-therapy. The study was conducted on 60 subjects with chronic hepatitis C infection before starting

antiviral therapy; 20 chronic hepatitis C, 20 cirrhotic patients and 20 HCC HCV positive as well as 10 healthy subjects negative

for HCV, HBV and HIV served as controls. IL-17 was quantitated after mitogen stimulated whole peripheral venous blood by

commercial enzyme linked immunosorbant assay (ELISA).Our results demonstrated a significant increase in serum levels of

IL-17 among cirrhotic and HCC patients infected with HCV. While in chronic hepatitis C virus cases, elevated IL-17 values were

non-significant compared to controls. It can be conclude that IL-17may play an important role in HCV immunopathogenesis.

It might be used as an indicator for cirrhosis and HCC as it promotes tumor growth by facilitating angiogenesis in tumor

microenvironment. Also, its therapeutic application needs to be furtherly evaluated by

in vivo

studies in experimental animals

aiming at future immunotherapy.

Keywords:

Chronic HCV, Cirrhosis, ELISA, HCC, Interleukin (IL )-17, T-helper 17 cell (Th17).

Biography

NohaA. Ghazy is a PhD student at the medical research institute (MRI) in Diagnostic and Molecular Microbiology. She had a master’s degree in Medical Microbiology

&Immunology from Alexandria University. Her current field is Lab quality assurance and lab accreditation officer keeping labs up to the international standards ISO

17025, ISO 15198 and the technical standards related to food, water and culture media preparation in central labs of Alexandria, Ministry of Health, Egypt. She is

CLA quality manager, specialist in medical microbiology, food and water microbiology.

nghazy2008@gmail.com

Noha A Ghazy et al., J Ecosys Ecograph 2018, Volume: 8

DOI: 10.4172/2157-7625-C2-035